000 01259 a2200361 4500
005 20250514193652.0
264 0 _c20040928
008 200409s 0 0 eng d
022 _a0004-8380
024 7 _a10.1111/j.1440-0960.2004.00091.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Brien, Timothy J
245 0 0 _aAcral dysesthesia and trastuzumab (Herceptin).
_h[electronic resource]
260 _bThe Australasian journal of dermatology
_cAug 2004
300 _a195-6 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aEdema
_xchemically induced
650 0 4 _aFemale
650 0 4 _aFoot
650 0 4 _aHand
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMiddle Aged
650 0 4 _aParesthesia
_xchemically induced
650 0 4 _aSyndrome
650 0 4 _aTrastuzumab
773 0 _tThe Australasian journal of dermatology
_gvol. 45
_gno. 3
_gp. 195-6
856 4 0 _uhttps://doi.org/10.1111/j.1440-0960.2004.00091.x
_zAvailable from publisher's website
999 _c14953910
_d14953910